TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Janssen R&D Ireland
Information provided by (Responsible Party):
Janssen R&D Ireland Identifier:
First received: April 8, 2010
Last updated: November 2, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2024
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)